Uploaded August 2011 | Updated September 2026, 1 week ago
Microfluidic Device of NIBIB Grantees Moves toward Clinical Applications
NIBIB Quantum Grant investigators have successfully developed a test capable of detecting a single cancer cell among the billions of normal cells in a simple blood sample. A patient sample of whole blood, which contains billions of normal cells and a small number of circulating tumor cells, flows through the microfluidic device. In this video, normal cells flow freely around and through the microposts, which are coated with an antibody that recognizes only tumor cells. The circulating tumor cells adhere to the coated microposts. The captured tumor cells can then be isolated for further characterization of the specific molecular profile of the cancer cells. Learn more about the researchers who developed the technology at: nibib.nih.gov/Research/Highlights/CTCMicrochipTemp and the Rockstars of Science rockstarsofscience.org/2010_rockdocs_toner.htm
Microfluidic Device of NIBIB Grantees Moves toward Clinical Applications
NIBIB Quantum Grant investigators have successfully developed a test capable of detecting a single cancer cell among the billions of normal cells in a simple blood sample. A patient sample of whole blood, which contains billions of normal cells and a small number of circulating tumor cells, flows through the microfluidic device. In this video, normal cells flow freely around and through the microposts, which are coated with an antibody that recognizes only tumor cells. The circulating tumor cells adhere to the coated microposts. The captured tumor cells can then be isolated for further characterization of the specific molecular profile of the cancer cells. Learn more about the researchers who developed the technology at: nibib.nih.gov/Research/Highlights/CTCMicrochipTemp and the Rockstars of Science rockstarsofscience.org/2010_rockdocs_toner.htm
